Water exchange reactivity and stability of cobalt polyoxometalates under catalytically relevant pH conditions: insight into water oxidation catalysis.

Water exchange on a molecular, purely inorganic cobalt-based water oxidation catalyst, [Co(4)(II)(H(2)O)(2)(α-P(1)W(9)O(34))(2)](10-) (1), in the catalytically relevant pH region (pH 6-10) is studied using (17)O-NMR spectroscopy and ultrahigh-resolution electrospray ionization mass spectrometry. The results are compared with those of the inactive [Co(II)(H(2)O)(1)Si(1)W(11)O(39)](6-) (2), which is stable in the same pH region. The results obtained provide mechanistic details of the elementary reaction step related to the water oxidation on homogeneous metal oxide catalysts under catalytically relevant conditions. It is shown that the structural integrity of 1 and 2 is maintained, no deprotonation of the aqua ligands on the Co(II) centers occurs, and the water exchange does not undergo any mechanistic changeover at the catalytic pH conditions. We have demonstrated that the water exchange process is influenced by the cluster environment surrounding the water binding sites and is fast enough to not be rate-limiting for the water oxidation catalysis.

Combined theoretical and mass spectrometry study of the formation-fragmentation of small polyoxomolybdates.

We investigate the assembly of small polyoxomolybdates using Car-Parrinello molecular dynamics simulations which show that there is an expansion of the coordination sphere of the Mo center from four to six in molybdate anions when the acidity of the solution is increased. With the help of complementary static density functional theory (DFT) calculations and electrospray ionization mass spectrometry experiments, we are able to postulate tentative mechanisms, with energy-cascade profiles, for the formation of the Lindqvist [Mo(6)O(19)](2-) anion. Similar to the family of isopolytungstates, it can be proposed that the [Mo(6)O(19)](2-) is formed by the aggregation of one molybdenum unit at a time; however, significant differences with respect to isopolytungstates are also found. The different behavior of chromates with respect to molybdates and tungstates is also considered.

Discovery of heteroatom-"embedded" Te {W18O54} nanofunctional polyoxometalates by use of cryospray mass spectrometry.

The cryo game: Heteroatom-embedded nanofunctional clusters are described that incorporate a [Te(VI)O(6)](6-) species contained within a {W(18)O(54)} cage. Not only does the tellurium-based species activate the {W(18)O(54)} cluster surface for assembly of larger nanoscale structures, such as [H(10)Te(VI) (2)W(58)O(198)](26-), it also undergoes a redox transformation inside the cluster from [Te(VI)O(6)](6-) to [Te(IV)O(3)](2-).

Unravelling the complexities of inorganic and supramolecular self-assembly in solution with electrospray and cryospray mass spectrometry.

Electrospray (ESI) and cryospray mass spectrometry (CSI-MS) are proving to be exceptionally versatile tools when used in conjunction with high resolution time-of-flight (TOF) systems to investigate the self-assembly of supramolecular architectures, inorganic coordination and organometallic compounds, labile molecules and clusters both from a structural and mechanistic point of view. In this feature article, we review very recent progress where mass spectrometry is being applied to highly labile and complex coordination and polyoxometalate (POM) cluster systems and we present some highlights from our initial electrospray and cryospray studies, which probe the self-assembly of inorganic cluster architectures. We discuss the major contributions of ESI and CSI-MS to labile and self-assembling inorganic architectures with great emphasis on future potential and ramifications for inorganic chemistry and the area of self-assembly as a whole.

Probing the self-assembly of inorganic cluster architectures in solution with cryospray mass spectrometry: growth of polyoxomolybdate clusters and polymers mediated by silver(I) ions.

Cryospray mass spectrometry (CSI-MS) has been used to probe the mechanism of self-assembly of polyoxometalate clusters in solution. By using CSI-MS and electronic absorbance spectroscopy it was possible to monitor in real-time the self-assembly of polymeric chains based on [Ag 2Mo 8O 26] (2-) n building blocks. The role of the Ag (I) ion in the solution state rearrangement of molybdenum Lindqvist ({Mo 6}) into the silver-linked beta-octamolybdate ({Mo 8}) structure (( n-C 4H 9) 4N) 2 n [Ag 2Mo 8O 26] n ( 1) is revealed in unprecedented detail. A monoanionic series, in particular [AgMo m O 3 m+1 ] (-) where m = 2 to 4, and series involving mixed oxidation state polyoxomolybdate species, which illustrate the in-solution formation of the (Ag{Mo 8}Ag) building blocks, have been observed. CSI-MS detection of species with increasing metal nuclearity concomitant with increasing organic cation contribution supports the hypothesis that the organic cations used in the synthesis play an important structure-directing role in polyoxometalate (POM) growth in solution. A real-time decrease in [{Mo 6}] and associated increase in [{Mo 8}] have been observed using CSI-MS and electronic absorbance spectroscopy, and the rate of {Mo 6} interconversion to {Mo 8} was found to decrease on increasing the size of the countercation. This result can be attributed to the steric bulk of larger organic groups hindering {Mo 6} to {Mo 8} rearrangement and hindering the contact between silver cations and molybdenum anions.

CD31 delays phagocyte membrane repolarization to promote efficient binding of apoptotic cells.

Homophilic ligation of CD31, a member of the Ig superfamily of adhesion receptors, promotes macrophage clearance of apoptotic leukocytes by a mechanism hitherto not described. In studying CD31-dependent regulation of beta1-integrin binding of fibronectin-coated Latex beads, we discovered a role for the voltage-gated potassium channel ether-à-go-go-related gene (ERG) as a downstream effector of CD31 signaling. ERG was identified by tandem mass spectrometry as a 140-kDa protein, which was selectively modified with biotin following the targeted delivery of a biotin-transfer reagent to CD31 using Fab fragments of an anti-CD31 mAb. Similar results were obtained with macrophages but not K562 cells, expressing a truncated cytoplasmic tail of CD31, which failed to regulate bead binding. Colocalization of CD31 with ERG was confirmed by immunofluorescence for K562 cells and macrophages. We now demonstrate that the resting membrane potential of macrophages is depolarized on contact with apoptotic cells and that CD31 inhibits the ERG current, which would otherwise function to repolarize. Sustained depolarization favored the firm binding of phagocytic targets, a prerequisite for efficient engulfment. Our results identify ERG as a downstream effector of CD31 in the regulation of integrin-dependent binding of apoptotic cells by macrophages.

CD31 promotes beta1 integrin-dependent engulfment of apoptotic Jurkat T lymphocytes opsonized for phagocytosis by fibronectin.

Phagocyte integrins, by binding "bridging" molecules, mediate the ingestion of late apoptotic cells and apoptotic bodies by mechanisms that remain obscure. We recently reported that human monocyte-derived macrophages capture viable and apoptotic human leukocytes through homophilic interactions involving CD31 and that CD31 then promotes the engulfment of apoptotic cells or the detachment of viable cells. We now report that CD31 homophilic interactions between phagocyte and target cells lead to activation of phagocyte alpha5beta1 integrin and the engulfment of apoptotic Jurkat T lymphocytes via a fibronectin (Fn) "bridge." Although Fn and serum served as an opsonin for beta1 integrin-dependent phagocytosis of apoptotic leukemic T cells, they failed to do so for neutrophils. Given the complexities and inherent variability of working with primary cells, we have refined our model to show that ligation of CD31 on THP-1 macrophages also regulates beta1 integrin-dependent phagocytosis of Fn-coated Latex beads. Thus, selective "tethering" of apoptotic leukocytes by phagocyte CD31 not only discriminates dying from viable cells but also selectively activates phagocyte integrins for the engulfment of apoptotic cells.

Promoting apoptosis in disease management: a panacea or Trojan horse?

In our enthusiasm to advocate apoptosis as a therapeutic strategy for the management of disease we need to be mindful that the clearance of apoptotic cells is itself immunomodulatory and that it may not always be as benign or beneficial as we think. Indeed, the existence of free apoptotic cells in situ may potentially be pathological, and not necessarily physiological, and any attempt to promote apoptosis in the absence of an appropriate phagocytic response for the treatment of, for example, inflammation or cancer might exacerbate or initiate an autoimmune pathology.